Richard Daniell

TEVA

Richard Daniell serves as Exec. VP, European Commercial at Teva Pharmaceutical Industries Limited (TEVA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$7.66M

Net Position

Net Seller

$7.66M

Companies Traded

TEVA

Active Period

Mar 2025 – Dec 2025

4 total trades

Most Recent

Sell TEVA

Dec 9, 2025 · $3.31M

Richard Daniell's Insider Trading at Teva Pharmaceutical Industries Limited (TEVA)

Buys

0 · $0.00

Sells

4 · $7.66M

Total Shares Bought

Total Shares Sold

389,051

TEVA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 9, 2025	Sell	115,468	$28.68	$3.31M
Mar 5, 2025	Sell	70,961	$15.91	$1.13M
Mar 4, 2025	Sell	140,372	$15.80	$2.22M
Mar 3, 2025	Sell	62,250	$16.06	$999.4K

Related Insiders

MIGNONE ROBERTO

Director

TEVASell · Dec 16, 2025

Amir Weiss

Chief Accounting Officer

TEVASell · Dec 16, 2025

Mark Sabag

See "Remarks"

TEVASell · Dec 9, 2025

Christine Fox

EVP, Head of U.S. Commercial

TEVASell · Nov 20, 2025

David R. McAvoy

EVP, Chief Legal Officer

TEVABuy · Sep 5, 2025

Placid Jover

See "Remarks"

TEVASell · Aug 1, 2025

Eric A Hughes

See "Remarks"

TEVASell · Aug 1, 2025

Eliyahu Sharon Kalif

EVP, Chief Financial Officer

TEVASell · Jun 12, 2025

Explore More Insider Trading Data

TEVA Insider Trading Activity

View all insider trades at Teva Pharmaceutical Industries Limited

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity